Late signals from CD27 prevent fas-dependent apoptosis of primary CD8 + T cells

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 2912-2921

  Dolfi, Douglas V ^a   Boesteanu, Alina C ^a   Petrovas, Constantinos ^a   Xia, Dong ^b   Butz, Eric A ^b   Katsikis, Peter D ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD70 ANTIGEN; FAS ANTIGEN; FAS LIGAND; NUCLEAR PROTEIN; BLOCKING ANTIBODY; CORE PROTEIN; MONOCLONAL ANTIBODY; NUCLEOPROTEIN (366 374), INFLUENZA VIRUS; NUCLEOPROTEIN (366-374), INFLUENZA VIRUS; PEPTIDE FRAGMENT; TNFSF7 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNOSTIMULATION; INFLUENZA; INFLUENZA VIRUS A; LYMPHOCYTE COUNT; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS IMMUNITY; ADOPTIVE TRANSFER; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG ANTAGONISM; GENETICS; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; TIME; TRANSPLANTATION; VIROLOGY;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD27; ANTIGENS, CD70; ANTIGENS, CD95; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; PEPTIDE FRAGMENTS; SIGNAL TRANSDUCTION; TIME FACTORS; VIRAL CORE PROTEINS;

EID: 49149109920     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.2912     Document Type: Article

References (51)

1. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8: 379-385.
2. Hintzen, R. Q., R. de Jong, S. M. Lens, M. Brouwer, P. Baars, and R. A. van Lier. 1993. Regulation of CD27 expression on subsets of mature T-lymphocytes. J. Immunol. 151: 2426-2435.
3. Kaech, S. M., S. Hemby, E. Kersh, and R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111: 837-851.
4. + T cell contraction is controlled by early inflammation. Nat. Immunol. 5: 809-817.
5. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2: 415-422.
6. + memory T cells. Nature 441: 890-894.
7. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7: 4472-4481.
8. Smith, C. A., H. J. Gruss, T. Davis, D. Anderson, T. Farrah, E. Baker, G. R. Sutherland, C. I. Brannan, N. G. Copeland, N. A. Jenkins, et al. 1993. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73: 1349-1360.
9. Smith, C. A., T. Davis, D. Anderson, L. Solam, M. P. Beckmann, R. Jerzy, S. K. Dower, D. Cosman, and R. G. Goodwin. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248: 1019-1023.
10. Song, J., S. Salek-Ardakani, P. R. Rogers, M. Cheng, L. Van Parijs, and M. Croft. 2004. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat. Immunol. 5: 150-158.
11. + T cell responses. Nat. Immunol. 3: 536-541.
12. Pollok, K. E., Y. J. Kim, Z. Zhou, J. Hurtado, K. K. Kim, R. T. Pickard, and B. S. Kwon. 1993. Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol. 150: 771-781.
13. Hintzen, R. Q., R. de Jong, S. M. Lens, and R. A. van Lier. 1994. CD27: marker and mediator of T-cell activation? Immunol. Today 15: 307-311.
14. + T cells. J. Exp. Med. 186: 1407-1418.
15. Sugita, K., M. J. Robertson, Y. Torimoto, J. Ritz, S. F. Schlossman, and C. Morimoto. 1992. Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. J. Immunol. 149: 1199-1203.
16. + B lymphocyte subset. J. Immunol. 148: 3700-3705.
17. Maurer, D., W. Holter, O. Majdic, G. F. Fischer, and W. Knapp. 1990. CD27 expression by a distinct subpopulation of human B lymphocytes. Eur. J. Immunol. 20: 2679-2684.
18. + naive T cell costimulation. J. Immunol. 153: 5422-5432.
19. Hintzen, R., S. Lens, M. Beckmann, R. Goodwin, D. Lynch, and R. van Lier. 1994. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J. Immunol. 152: 1762-1773.
20. van Lier, R., J. Borst, T. Vroom, H. Klein, P. Van Mourik, W. Zeijlemaker, and C. Melief. 1987. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 139: 1589-1596.
21. Goodwin, R. G., M. R. Alderson, C. A. Smith, R. J. Armitage, T. VandenBos, R. Jerzy, T. W. Tough, M. A. Schoenborn, T. Davis-Smith, K. Hennen, et al. 1993. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73: 447-456.
22. Hintzen, R. Q., R. de Jong, C. E. Hack, M. Chamuleau, E. F. de Vries, I. J. ten Berge, J. Borst, and R. A. van Lier. 1991. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J. Immunol. 147: 29-35.
23. Akiba, H., Y. Miyahira, M. Atsuta, K. Takeda, C. Nohara, T. Futagawa, H. Matsuda, T. Aoki, H. Yagita, and K. Okumura. 2000. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J. Exp. Med. 191: 375-380.
24. Tesselaar, K., Y. Xiao, R. Arens, G. M. W. van Schijndel, D. H. Schuurhuis, R. E. Mebius, J. Borst, and R. A. W. van Lier. 2003. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J. Immunol. 170: 33-40.
25. Agematsu, K., T. Kobata, K. Sugita, T. Hirose, S. F. Schlossman, and C. Morimoto. 1995. Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. J. Immunol. 154: 3627-3635.
26. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
27. Hendriks, J., L. A. Gravestein, K. Tesselaar, R. A. van Lier, T. N. Schumacher, and J. Borst. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1: 433-440.
28. Arens, R., K. Tesselaar, P. A. Baars, G. M. van Schijndel, J. Hendriks, S. T. Pals, P. Krimpenfort, J. Borst, M. H. van Oers, and R. A. van Lier. 2001. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion. Immunity 15: 801-812.
29. Tesselaar, K., R. Arens, G. M. van Schijndel, P. A. Baars, M. A. van der Valk, J. Borst, M. H. van Oers, and R. A. van Lier. 2003. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat. Immunol. 4: 49-54.
30. + memory T cells and their capacity for secondary expansion. J Immunol. 175: 1665-1676.
31. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434: 88-93.
32. Tateyama, M., N. Oyaizu, T. W. McCloskey, S. Than, and S. Pahwa. 2000. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway. Blood 96: 195-202.
33. + T cell responses through regulated FasL expression. Immunity 23: 649-659.
34. Gravestein, L. A., W. van Ewijk, F. Ossendorp, and J. Borst. 1996. CD27 cooperates with the pre-T cell receptor in the regulation of murine T cell development. J. Exp. Med. 184: 675-685.
35. Moyron-Quiroz, J. E., J. Rangel-Moreno, K. Kusser, L. Hartson, F. Sprague, S. Goodrich, D. L. Woodland, F. E. Lund, and T. D. Randall. 2004. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10: 927-934.
36. + T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
37. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
38. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342.
39. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
40. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-480.
41. + T-helper and a T-killer cell. Nature 393: 474-478.
42. Sun, M., K. T. Ames, I. Suzuki, and P. J. Fink. 2006. The cytoplasmic domain of Fas ligand costimulates TCR signals. J. Immunol. 177: 1481-1491.
43. Alderson, M. R., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178: 2231-2235.
44. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-318.
45. Roths, J. B., E. D. Murphy, and E. M. Eicher. 1984. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159: 1-20.
46. Morse, H. C., III, J. B. Roths, W. F. Davidson, W. Y. Langdon, T. N. Fredrickson, and J. W. Hartley. 1985. Abnormalities induced by the mutant gene, lpr: patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr. J. Exp. Med. 161: 602-616.
47. Jaleco, S., L. Swainson, V. Dardalhon, M. Burjanadze, S. Kinet, and N. Taylor. 2003. Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J. Immunol. 171: 61-68.
48. Refaeli, Y., L. Van Parijs, C. A. London, J. Tschopp, and A. K. Abbas. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8: 615-623.
49. Lenardo, M. J. 1991. Interleukin-2 programs mouse α β T lymphocytes for apoptosis. Nature 353: 858-861.
50. Blattman, J. N., J. M. Grayson, E. J. Wherry, S. M. Kaech, K. A. Smith, and R. Ahmed. 2003. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9: 540-547.
51. + T cell without effector differentiation. Proc. Natl. Acad. Sci. USA 103: 19454-19459.